Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

21.56

-0.29 (-1.33%)

At close: Jun 10, 2025, 4:00 PM

21.61

+0.05 (0.23%)

After-hours: Jun 10, 2025, 7:21 PM EDT

Rigel Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Operating Revenue	203.08	179.28	115.78	115.74	138.74	108.62	Upgrade
Other Revenue	-	-	0.1	-	-	-	Upgrade
Revenue	203.08	179.28	115.88	115.74	138.74	108.62	Upgrade
Revenue Growth (YoY)	70.16%	54.71%	0.12%	-16.57%	27.73%	83.21%	Upgrade
Cost of Revenue	46.82	42.03	31.63	62.02	66.32	61	Upgrade
Gross Profit	156.26	137.25	84.25	53.72	72.42	47.63	Upgrade
Selling, General & Admin	112.33	113.06	105.74	112.45	91.89	76.6	Upgrade
Operating Expenses	112.33	113.06	105.74	112.45	91.89	76.6	Upgrade
Operating Income	43.93	24.19	-21.49	-58.73	-19.48	-28.97	Upgrade
Interest Expense	-7.9	-7.92	-6.87	-3.71	-4.86	-1.35	Upgrade
Interest & Investment Income	2.09	2.09	2.27	0.68	0.05	0.58	Upgrade
EBT Excluding Unusual Items	38.12	18.37	-26.09	-61.75	-24.29	-29.74	Upgrade
Merger & Restructuring Charges	-	-	-	-1.32	-3.52	-	Upgrade
Other Unusual Items	-	-	1	4.5	10.5	-	Upgrade
Pretax Income	38.12	18.37	-25.09	-58.57	-17.31	-29.74	Upgrade
Income Tax Expense	0.95	0.88	-	-	0.61	-	Upgrade
Net Income	37.18	17.49	-25.09	-58.57	-17.91	-29.74	Upgrade
Net Income to Common	37.18	17.49	-25.09	-58.57	-17.91	-29.74	Upgrade
Shares Outstanding (Basic)	18	18	17	17	17	17	Upgrade
Shares Outstanding (Diluted)	18	18	17	17	17	17	Upgrade
Shares Change (YoY)	2.34%	1.64%	2.07%	-0.00%	1.03%	0.81%	Upgrade
EPS (Basic)	2.11	0.99	-1.44	-3.44	-1.05	-1.76	Upgrade
EPS (Diluted)	2.08	0.99	-1.44	-3.44	-1.05	-1.76	Upgrade
Free Cash Flow	35.56	31.44	-5.74	-74.21	5.25	-53.45	Upgrade
Free Cash Flow Per Share	1.99	1.78	-0.33	-4.35	0.31	-3.17	Upgrade
Gross Margin	76.94%	76.56%	72.70%	46.41%	52.20%	43.84%	Upgrade
Operating Margin	21.63%	13.49%	-18.55%	-50.74%	-14.04%	-26.67%	Upgrade
Profit Margin	18.31%	9.75%	-21.65%	-50.61%	-12.91%	-27.38%	Upgrade
Free Cash Flow Margin	17.51%	17.53%	-4.96%	-64.11%	3.79%	-49.20%	Upgrade
EBITDA	46.36	26.42	-20.25	-57.73	-18.31	-28.27	Upgrade
EBITDA Margin	22.83%	14.74%	-17.48%	-49.88%	-13.20%	-26.02%	Upgrade
D&A For EBITDA	2.43	2.23	1.24	1	1.16	0.71	Upgrade
EBIT	43.93	24.19	-21.49	-58.73	-19.48	-28.97	Upgrade
EBIT Margin	21.63%	13.49%	-18.55%	-50.74%	-14.04%	-26.67%	Upgrade
Effective Tax Rate	2.48%	4.80%	-	-	-	-	Upgrade
Revenue as Reported	203.08	179.28	116.88	120.24	149.24	108.62	Upgrade

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q